Our Commitment

Vision

Affibody’s vision is to build a sustainable Swedish biotechnology company with global reach by developing and commercializing innovative drugs based on the company’s unique patented technology platform, and so improve the lives of patients suffering from serious diseases.

Mission

Our mission is to address medical needs with pioneering treatments that can improve the lives of patients. We do this by being a science-driven company with the technological leadership and expertise to take drug candidates all the way from the laboratory to clinical use. We have a long-term commitment to developing and commercializing novel drugs based on our innovative technology platform. We also strive to continuously generate shareholder value in a sustainable way and to consolidate our position as a highly valued employer and partner.

Strategy

Our strategy is to build an integrated biotech company with expertise in research, development, manufacturing, and commercialization. Each of the molecules in the company’s extensive pipeline is based on the strengths of our differentiated proprietary platform and strategically focuses on indications where our technology offers a significant competitive advantage. Throughout our research and development, our strategy is to have a clear product vision focusing on medical needs, while balancing scientific, regulatory, and commercial risks. We ensure a continuous inflow of ideas and potential projects through close collaboration with an extensive network of reputable researchers and clinicians as we operate an efficient research and development process focused on our core competencies. In order to expand our capacity and maximize the value of our technology, we pursue extensive collaboration with the pharmaceutical industry and academic community.